NCT05518812 2024-09-19
Carboprost (Hemabate) for Fibroid Resection
Northwestern University
Phase EARLY_PHASE1 Completed
Clinical Trials
20 trialsNCT02164461 2024-05-20
Axalimogene Filolisbac (ADXS11-001) High Dose in Women With Human Papillomavirus (HPV) + Cervical Cancer
Advaxis, Inc.
Phase 1 Completed
NCT03629626 2023-04-25
ERAS
Shandong University
Phase NA Completed
NCT01462890 2022-07-20
BOOST
AGO Study Group
Phase 3 Completed
NCT03562897 2022-07-06
Evaluation of Ocoxin-Viusid® in Advanced or Metastatic Ovarian Epithelial Cancer
Catalysis SL
Phase 2 Completed
NCT00290459 2021-03-30
Prognostic Markers of Gynecologic Cancers
University of Louisville
Completed
NCT03916445 2020-06-04
Resilience and Quality of Life in Patients With Gynaecological Carcinomas and Chronic Gynaecological Diseases
University Hospital, Basel, Switzerland
Completed
NCT03347409 2020-02-07
ERASGYNBS001
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
Phase NA Completed
NCT01523678 2019-07-10
Weekly Paclitaxel/Carboplatin With Neupogen in Gynaecological Cancers
Belgian Gynaecological Oncology Group
Phase 2 Completed
NCT01628432 2018-10-22
SALPINGOVA
University Hospital, Tours
Phase NA Completed
NCT02139267 2017-07-12
Dose-finding, Safety Study of Plasmid DNA Therapeutic Vaccine to Treat Cervical Intraepithelial Neoplasia
Genexine, Inc.
Phase 2 Completed
NCT01576380 2017-02-27
A Phase II Study to Evaluate Efficacy and Safety of Dovitinib (TKI258) in Advanced Scirrhous Gastric Carcinoma Patients
Novartis
Phase 2 Completed
NCT01460979 2016-02-29
Efficacy,Tolerability,Safety of Temsirolimus in Women With Platinum-refractory Ovarian Carcinoma or Advanced Endometrial Carcinoma
AGO Study Group
Phase 2 Completed
NCT00365716 2015-10-07
Dose-Ranging Study of Quadrivalent Human Papillomavirus (HPV) (Types 6,11,16,18) L1 Virus-Like Particle (VLP) Vaccine (V501-007)(COMPLETED)
Merck Sharp & Dohme LLC
Phase 2 Completed
NCT01379534 2015-05-20
A Phase II Study to Evaluate the Efficacy of TKI258 for the Treatment of Patients With FGFR2 Mutated or Wild-type Advanced and/or Metastatic Endometrial Cancer
Novartis
Phase 2 Completed
NCT00604994 2013-08-20
LEGS
Queensland Centre for Gynaecological Cancer
Completed
NCT00749502 2013-07-25
A Study of MK4827 in Participants With Advanced Solid Tumors or Hematologic Malignancies (MK-4827-001 AM8)
Tesaro, Inc.
Phase 1 Completed
NCT00050414 2013-01-10
A Study of Trabectedin in Patients With Advanced Ovarian Cancer
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Phase 2 Completed
NCT01523652 2012-02-01
Pharmacokinetic Study on the Administration of Nadroparin Dosing Serum HGF in Gynecological Patients
Azienda Ospedaliera San Giovanni Battista
Completed
NCT00526331 2012-01-16
Evaluation of Arterial Pressure Based Cardiac Output for Goal-Directed Perioperative Therapy
M.D. Anderson Cancer Center
Phase 4 Completed